Projects

Projects

Safety and efficacy of Hepatitis B vaccines

Our report to the WHO Safety and efficacy from randomized controlled trials and observational studies of childhood schedules using hepatitis B vaccines informed the WHO position paper Hepatitis B vaccines: WHO position paper – July 2017

Efficacy and immunogenicity of human papillomavirus vaccines

Our report to the WHO Randomized controlled trials of human papillomavirus vaccines: Systematic reviews prepared by Cochrane Response, London, UK informed the WHO position paper Human papillomavirus vaccines: WHO position paper, May 2017

Incidence and prevalence of anogenital warts

Our report to the WHO: Anogenital warts: Incidence, prevalence, self-reported history & quality of life

NICE depression guideline

Our extracted data informed the NICE depression guideline update (consultation draft): Depression in adults: treatment and management

Safety, efficacy, and immunogenicity of typhoid vaccines

Summary of findings tables used in WHO SAGE meeting October 2017: Typhoid Vi-polysaccharide vaccine versus placebo or control vaccine in children and adults; Typhoid Ty21a vaccine versus placebo or control vaccine in children and adults

Robot assisted surgery for hysterectomy

Targeted Update: ‘Robot-assisted surgery in women undergoing hysterectomy’
Case study: A Targeted Update commissioned by an HTA agency produced within 9 weeks with support from a CRG

Our Targeted update contributed to the Swiss medical board appraisal and assessment of robot-assisted surgery

WHO guideline recommendations on digital interventions for health system strengthening

Cochrane Response contributed to the evidence summaries that informed the WHO guideline recommendations on digital interventions for health system strengthening, further details can be found on the Cochrane.org blog

WHO interim guidelines for the treatment of gambiense human African trypanosomiasis

Cochrane Response provided the Evidence summary: systematic review of oral fexinidazole as first line treatment for gambiense Human African Trypanosomiasis, that informed the WHO interim guidelines for the treatment of gambiense human African trypanosomiasis